Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.
about
Management of borderline resectable pancreatic cancerBorderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications.Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.Validation of group B borderline resectable pancreatic cancer: retrospective analysis.Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in OncologyThe Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyNeoadjuvant therapy for potentially resectable pancreatic cancer: an emerging paradigm?Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter?Novel directions in neoadjuvant therapy for pancreas adenocarcinoma.Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer.Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancer.Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort studyHome-based exercise during preoperative therapy for pancreatic cancer.Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy.Surgery for pancreatic cancer: critical radiologic findings for clinical decision making.Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.
P2860
Q26781445-5F4C6DC8-A839-4ED5-9F85-541AA9C27296Q33436503-951D2863-6C61-4902-A797-5C4759405E86Q33558951-85BCBA3A-09A9-48DA-8B1F-BB9F051E71B8Q34182126-6D408EBD-8F21-454D-BBA7-2D93F6576AE6Q36009614-E3D13429-3C72-4D53-A882-45FE2BCFD146Q36025049-0769D1E6-AB0A-47E0-8EE2-8AF18D328DE5Q37539690-999B1359-8DF3-40DD-A7FA-42619389F6B3Q38074622-1F071F2C-C058-4A9F-A6B7-F6B3181D9682Q38180310-246D84D8-21A8-40DC-89A2-DD0CE2F5BDADQ38357201-5F98C027-414E-4BB9-9E27-1E1FD640D181Q38371662-F558CB3C-D336-43CC-B5AC-793687F1EADCQ38950663-12833021-A5AE-40A9-9215-588AF37B6B2DQ38998202-6814E5DD-30CE-4A56-BC83-FEEF3325C897Q39199977-FC89DA1F-81EA-4968-907F-6F2562BEE064Q41491695-50278D3D-3637-4DE5-870F-05A2E714E357Q41545288-C97DD3C4-B365-432D-A406-B81DFF2B7BB4Q48121758-5C96E7B0-771F-4028-9823-BA4C07C86C8AQ48136772-731272C9-70A2-48DF-A2A7-E7FE9674E742Q49835589-54D02D51-7CCD-48FC-841C-AF401F814EA3Q51751748-75FE3AA6-4E87-4706-A4CE-3B98D208A3A9Q51772050-3978FA57-45B5-488A-BEFD-E69015E95CBE
P2860
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Defined clinical classificatio ...... ated with neoadjuvant therapy.
@en
Defined clinical classificatio ...... ated with neoadjuvant therapy.
@nl
type
label
Defined clinical classificatio ...... ated with neoadjuvant therapy.
@en
Defined clinical classificatio ...... ated with neoadjuvant therapy.
@nl
prefLabel
Defined clinical classificatio ...... ated with neoadjuvant therapy.
@en
Defined clinical classificatio ...... ated with neoadjuvant therapy.
@nl
P2093
P2860
P1476
Defined clinical classificatio ...... ated with neoadjuvant therapy.
@en
P2093
Aparna Balachandran
Ching-Wei D Tzeng
Christopher H Crane
David R Fogelman
Eddie K Abdalla
Gauri R Varadhachary
Jason B Fleming
Jean-Nicolas Vauthey
Jeffrey E Lee
Lianchun Xiao
P2860
P2888
P304
P356
10.1245/S10434-011-2211-4
P577
2012-01-19T00:00:00Z
P6179
1051284994